Renal failure means your kidneys can no longer filter waste and excess fluid from your blood effectively. It comes in two forms: acute, where kidney function drops suddenly over hours or days, and chronic, where it declines gradually over months or years. Both types can become life-threatening, but they differ significantly in causes, progression, and outlook.
Acute vs. Chronic Kidney Failure
Acute kidney injury (AKI) is a rapid decline in kidney function, typically detected by a sudden spike in creatinine (a waste product) in the blood, often accompanied by reduced urine output. Common triggers include severe dehydration, blood loss, infections, medication toxicity, or anything that suddenly reduces blood flow to the kidneys. Many cases of AKI are reversible if the underlying cause is treated quickly.
Chronic kidney disease (CKD) develops over years and is usually irreversible. The damage accumulates silently, and most people have no symptoms until the disease is well advanced. CKD is classified into five stages based on your estimated glomerular filtration rate (eGFR), a measure of how efficiently your kidneys filter blood. Stage 1 means your filtration rate is still normal (above 90 mL/min) but there are signs of kidney damage. By Stage 5, filtration has dropped below 15 mL/min, a threshold known as end-stage kidney disease, where dialysis or transplant becomes necessary.
These two conditions are not entirely separate. Having chronic kidney disease raises your risk of an acute episode, and a bout of acute kidney injury can accelerate the progression to chronic disease. Both also independently raise the risk of cardiovascular problems like heart attack and stroke.
How Kidneys Lose Function
Your kidneys contain roughly one million filtering units called nephrons. When disease or injury destroys some of those nephrons, the surviving ones compensate by working harder and growing larger. This keeps your overall filtration rate stable for a while, which is why bloodwork can look normal even after you’ve lost a significant portion of kidney function. Serum creatinine, the most common blood marker, doesn’t rise noticeably until kidney function has already dropped by about 50%.
The problem is that this compensatory effort eventually backfires. The overworked nephrons face higher pressure and greater metabolic demand than their blood supply can support. The resulting oxygen shortage generates damaging molecules and triggers inflammation. Specialized cells on the kidney’s filtering surface, called podocytes, must stretch to cover a larger area but cannot multiply to keep up. When they fail to cover the filter membrane, scar tissue forms and more nephrons are lost, forcing the remaining ones to work even harder. This self-reinforcing cycle is why chronic kidney disease tends to accelerate as it progresses.
Common Causes
Diabetes and high blood pressure are the two leading drivers of chronic kidney failure. Persistently elevated blood sugar damages the tiny blood vessels inside the kidneys, while uncontrolled blood pressure subjects those same vessels to mechanical stress year after year. Glomerulonephritis, a group of diseases that inflame the kidney’s filtering units, is another major cause. Less common contributors include polycystic kidney disease (a genetic condition), prolonged urinary tract obstruction, and repeated or severe episodes of acute kidney injury.
Symptoms and How They Progress
Early-stage kidney disease is often called a “silent” condition for good reason. Stages 1 through 3 frequently produce no noticeable symptoms. By the time you feel something is wrong, significant damage has usually already occurred.
As filtration continues to decline, waste products called uremic toxins build up in the blood. Symptoms typically appear once filtration drops below about 10 to 20 mL/min, though people with diabetes may notice them slightly earlier. The initial signs tend to be vague: fatigue, loss of appetite, nausea, and muscle cramps. Itching is common. Neurological changes creep in gradually, including forgetfulness, trouble concentrating, and difficulty sleeping. Because these symptoms develop slowly, patients themselves often don’t notice the cognitive decline.
Without treatment, the buildup of toxins progresses to a state called uremic encephalopathy, marked by increasing confusion, disorientation, emotional instability, and unusual behavior. In severe cases this can lead to stupor and coma. Other late signs include persistent vomiting, a metallic taste in the mouth, restless legs, and swelling in the legs and around the eyes from fluid retention.
Bone and Mineral Complications
One of the less obvious consequences of kidney failure is bone disease. Healthy kidneys activate vitamin D, which helps your body absorb calcium from food. They also excrete phosphorus, a mineral found in dairy, meat, and processed foods. When kidneys falter, phosphorus accumulates in the blood while active vitamin D and calcium levels drop.
This imbalance triggers the parathyroid glands (four tiny glands in the neck) to release excessive amounts of parathyroid hormone, a condition called secondary hyperparathyroidism. The hormone pulls calcium out of bones to restore blood calcium levels. Over time this weakens the skeleton, a condition called renal osteodystrophy. Parathyroid hormone levels typically start rising once eGFR falls below 60 mL/min, meaning bone changes can begin well before someone reaches end-stage disease. The long-term result is bones that are more prone to fractures and joints that ache chronically.
How Kidney Failure Is Detected
Two simple tests form the backbone of diagnosis. A blood test estimates your GFR by measuring creatinine and plugging it into a formula that accounts for age and sex. A urine test checks for albumin, a protein that healthy kidneys keep in the blood. The urine albumin-to-creatinine ratio is categorized into three tiers: under 30 mg/g is normal, 30 to 300 mg/g indicates moderate protein leakage, and above 300 mg/g signals severe leakage. Combining your GFR stage with your albumin category gives doctors a more complete picture of how much kidney damage is present and how quickly it may progress.
Because creatinine is a lagging indicator, rising only after substantial function is lost, routine screening is especially important for people with diabetes, high blood pressure, or a family history of kidney disease.
Treatment at Different Stages
In early and moderate stages, treatment focuses on slowing progression. Controlling blood pressure and blood sugar are the two most impactful interventions. A class of medications originally designed for diabetes (SGLT2 inhibitors) has shown strong kidney-protective effects even in people without diabetes, and international guidelines now recommend them as part of standard CKD management. Limiting dietary sodium and phosphorus also helps reduce the workload on remaining nephrons.
Once kidney function drops low enough that the body can no longer manage waste and fluid balance on its own, renal replacement therapy becomes necessary. The two main options are dialysis and kidney transplant.
Dialysis
Hemodialysis filters your blood through a machine. The most common setup involves traveling to a dialysis center three times a week for sessions lasting several hours. Home hemodialysis is also available, and doing it five to seven times per week at home has been linked to significantly better outcomes, including longer survival. Either way, a surgically created access point in the arm or a catheter is needed to connect to the machine.
Peritoneal dialysis takes a different approach. A permanent catheter is placed in the abdomen, and you fill the abdominal cavity with a cleansing solution that draws waste through the lining of the abdominal wall. This is done every day, but because it happens at home and doesn’t require a machine, the total time commitment is often less than traveling to and from a hemodialysis center, waiting, and recovering afterward.
Kidney Transplant
Transplant offers the best long-term outcomes. Five-year graft survival rates reach 90% for younger adults (ages 18 to 34) who receive a kidney from a living donor, and 81.4% for those who receive a kidney from a deceased donor. Even for recipients aged 65 and older, five-year patient survival is 83% with a living donor kidney and 72% with a deceased donor kidney.
The main barrier is availability. About 36% of people on the waiting list in 2022 had been waiting less than one year, but 12.4% had been waiting five years or longer. Living donor transplants bypass much of this wait, which is one reason outcomes are better: the kidney spends less time without blood flow, and the recipient spends less time on dialysis beforehand.

